Recent progress of METTL3 inhibitors for cancer therapeutics: design, optimization and potential applications
{{output}}
Acute myeloid leukaemia (AML) is a clonal proliferative malignant hematologic disease of hematopoietic stem cells, characterized by the accumulation of immature progenitor cells and the inhibition of hematopoietic function due to blocked differentiation, which... ...
